Skip to main content
SpringerLink
Log in

Use of Glancing Angle X-Ray Powder Diffractometry to Depth-Profile Phase Transformations During Dissolution of Indomethacin and Theophylline Tablets

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. The purpose of this study was (i) to develop glancing angle x-ray powder diffractometry (XRD) as a method for profiling phase transformations as a function of tablet depth; and (ii) to apply this technique to (a) study indomethacin crystallization during dissolution of partially amorphous indomethacin tablets and to (b) profile anhydrate → hydrate transformations during dissolution of theophylline tablets.

Methods. The intrinsic dissolution rates of indomethacin and theophylline were determined after different pharmaceutical processing steps. Phase transformations during dissolution were evaluated by various techniques. Transformation in the bulk and on the tablet surface was characterized by conventional XRD and scanning electron microscopy, respectively. Glancing angle XRD enabled us to profile these transformations as a function of depth from the tablet surface.

Results. Pharmaceutical processing resulted in a decrease in crystallinity of both indomethacin and theophylline. When placed in contact with the dissolution medium, while indomethacin recrystallized, theophylline anhydrate rapidly converted to theophylline monohydrate. Due to intimate contact with the dissolution medium, drug transformation occurred to a greater extent at or near the tablet surface. Glancing angle XRD enabled us to depth profile the extent of phase transformations as a function of the distance from the tablet surface. The processed sample (both indomethacin and theophylline) transformed more rapidly than did the corresponding unprocessed drug. Several challenges associated with the glancing angle technique, that is, the effects of sorbed water, phase transformations during the experimental timescale, and the influence of phase transformation on penetration depth, were addressed.

Conclusions. Increased solubility, and consequently dissolution rate, is one of the potential advantages of metastable phases. This advantage is negated if, during dissolution, the metastable to stable transformation rate ≫ dissolution rate. Glancing angle XRD enabled us to quantify and thereby profile phase transformations as a function of compact depth. The technique has potential utility in monitoring surface reactions, both chemical decomposition and physical transformations, in pharmaceutical systems.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. L. Lachman, H. A. Lieberman, and J. L. Kanig. The Theory and Practice of Industrial Pharmacy. Lea & Febiger, Philadelphia, 1986.

    Google Scholar 

  2. A. J. Aguiar, K. C. J. John, A. W. Kinkel, and J. C. Samyn. Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate. J. Pharm. Sci. 56:847-853 (1967).

    Google Scholar 

  3. K. Kimura, F. Hirayama, and K. Uekama. Characterization of tolbutamide polymorphs (Burger's forms II and IV) and polymorphic transition behavior. J. Pharm. Sci. 88:385-391 (1999).

    Google Scholar 

  4. Y. Kobayashi, S. Ito, S. Itai, and K. Yamamoto. Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate. Int. J. Pharm. 193:137-146 (2000).

    Google Scholar 

  5. Federal Register Part V and F. Department of Health and Human Services. International Conference on Harmonization; Draft Guidance on Specifications: Test procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances; Notice, 1997.

  6. Y. Chikaraishi, M. Otsuka, and Y. Matsuda. Dissolution phenomenon of the piretanide amorphous form involving phase change. Chem. Pharm. Bull. 44:2111-2115 (1996).

    Google Scholar 

  7. A. T. Florence and E. G. Salole. Changes in crystallinity and solubility on comminution of digoxin and observations on spironolactone and estradiol. J. Pharm. Pharmacol. 28:637-642 (1976).

    Google Scholar 

  8. Y. Kato and M. Kohketsu. Relationship between polymorphism and bioavailability of amobarbital in the rabbit. Chem. Pharm. Bull. 29:268-272 (1981).

    Google Scholar 

  9. M. Ono, Y. Tozuka, T. Oguchi, S. Yamamura, and K. Yamamoto. Effects of dehydration temperature on water vapor adsorption and dissolution behavior of carbamazepine. Int. J. Pharm. 239:1-12 (2002).

    Google Scholar 

  10. B. C. Hancock and M. Parks. What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 17:397-404 (2000).

    Google Scholar 

  11. H. Vromans, G. K. Bolhuis, C. F. Lerk, and K. D. Kussendrager. Studies on tableting properties of lactose. VIII. The effect of variations in primary particle size, percentage of amorphous lactose and addition of a disintegrant on the disintegration of spray-dried lactose tablets. Int. J. Pharm. 39:201-206 (1987).

    Google Scholar 

  12. M. F. Doerner and S. Brennan. Strain distribution in thin aluminum films using x-ray depth profiling. J. Appl. Phys. 63:126-131 (1988).

    Google Scholar 

  13. B. L. Ballard, X. Zhu, P. K. Predecki, D. Albin, A. Gabor, J. Tuttle, and R. Noufi. Determination of composition and phase depth-profiles in multilayer and gradient solid solution photovoltaic films using grazing incidence X-ray diffraction. Adv. X-Ray Anal. 38:269-276 (1995).

    Google Scholar 

  14. P. Eisenberger and W. C. Marra. X-ray diffraction study of the germanium (001) reconstructed surface. Phys. Rev. Lett. 46:1081-1084 (1981).

    Google Scholar 

  15. L. G. Parratt. Surface studies of solids by total reflection of X-rays. Phys. Rev. 95:359-369 (1954).

    Google Scholar 

  16. X. Zhu, B. Ballard, and P. Predecki. Determination of z-profiles of diffraction data from tau-profiles using a numerical linear inversion method. Adv. X-Ray Anal. 38:255-262 (1995).

    Google Scholar 

  17. T. C. Huang. Surface and ultra-thin film characterization by grazing-incidence asymmetric Bragg diffraction. Adv. X-Ray Anal. 33:91-99 (1990).

    Google Scholar 

  18. B. E. Warren. X-Ray Diffraction. Addison Wesley, Reading, MA, 1969.

    Google Scholar 

  19. M. Otsuka, T. Matsumoto, and N. Kaneniwa. Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding. Chem. Pharm. Bull. 34:1784-1793 (1986).

    Google Scholar 

  20. E. Suzuki, K. Shimomira, and K. Sekiguchi. Thermochemical study of theophylline and its hydrate. Chem. Pharm. Bull. 37:493-497 (1989).

    Google Scholar 

  21. K. R. Morris, U. J. Griesser, C. J. Eckhardt, and J. G. Stowell. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv. Drug Del. Rev. 48:91-114 (2001).

    Google Scholar 

  22. J. H. Collett, J. A. Rees, and N. A. Dickinson. Some parameters describing the dissolution rate of salicylic acid at controlled pH. J. Pharm. Pharmacol. 24:724-728 (1972).

    Google Scholar 

  23. C. Doherty and P. York. Mechanisms of dissolution of frusemide/PVP solid dispersions. Int. J. Pharm. 34:197-205 (1987).

    Google Scholar 

  24. M. Otsuka and N. Kaneniwa. A kinetic study of the crystallization process of noncrystalline indomethacin under isothermal conditions. Chem. Pharm. Bull. 36:4026-4032 (1988).

    Google Scholar 

  25. M. Yoshioka, B. C. Hancock, and G. Zografi. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. J. Pharm. Sci. 83:1700-1705 (1994).

    Google Scholar 

  26. V. Andronis, M. Yoshioka, and G. Zografi. Effects of sorbed water on the crystallization of indomethacin from the amorphous state. J. Pharm. Sci. 86:346-351 (1997).

    Google Scholar 

  27. M. O'Brien, J. McCauley, and E. Cohen. Indomethacin. In K. Florey (ed.), Analytical Profiles of Drug Substances, Vol. 13. Academic Press, San Diego, 1984, pp. 211-238.

    Google Scholar 

  28. P. Predecki. Determination of depth profiles from X-ray diffraction data. Powder Diffraction 8:122-126 (1993).

    Google Scholar 

  29. Powder Diffraction File 26-1893. International Centre for Diffraction Data, Newtown Square, PA, 1997.

  30. S. Budaveri, M. J. O'Neil, A. Smith, P. E. Heckelman, and J. F. Kinneary. The Merck Index. Merck & Co., Whitehouse Station, NJ, 1996.

    Google Scholar 

  31. Powder Diffraction File 27-1977. International Centre for Diffraction Data, Newtown Square, PA, 1997.

  32. R. Jenkins. New directions in the X-ray diffraction analysis of organic materials. Adv. X-Ray Anal. 35:653-660 (1991).

    Google Scholar 

  33. T. Ely, P. K. Predecki, and I. C. Noyan. A method for obtaining stress-depth profiles by absorption constrained profile fitting of diffraction peaks. Adv. X-Ray Anal. 43:1-10 (2000).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, 55455

    Smita Debnath & Raj Suryanarayanan

  2. Engineering Department, University of Denver, Denver, Colorado, 80208

    Paul Predecki

Authors
  1. Smita Debnath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul Predecki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Raj Suryanarayanan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Raj Suryanarayanan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Debnath, S., Predecki, P. & Suryanarayanan, R. Use of Glancing Angle X-Ray Powder Diffractometry to Depth-Profile Phase Transformations During Dissolution of Indomethacin and Theophylline Tablets. Pharm Res 21, 149–159 (2004). https://doi.org/10.1023/B:PHAM.0000012163.89163.f8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:PHAM.0000012163.89163.f8

Search

Navigation